×
ADVERTISEMENT

naloxone

FDA Approves Second OTC Naloxone Nasal Spray

This is the second nonprescription naloxone product the FDA has approved.

AUGUST 4, 2023

Ending the Opioid Crisis: Are the Tools Within Reach?

According to the latest data from the CDC, a record 108,279 Americans lost their lives to drug overdoses between ...

JUNE 29, 2023

OTC Naloxone and the Impactful Anesthesiologist

The FDA approved naloxone at the end of March as an OTC medication, vastly increasing our ability to tackle the ...

JUNE 12, 2023

‘We Are Saving Lives’: The Long Journey to FDA Approval for OTC Naloxone

Efforts to increase access to naloxone—even for harm reduction programs—were still meeting distribution ...

MAY 2, 2023

Spike in Opioid Overdose Deaths Prompts Naloxone Without a Prescription in Central New York

The state looks to improve access to the overdose drug during an unprecedented surge of opioid-related deaths.

SEPTEMBER 28, 2022

Wearable Device Would Identify, Treat Potential Opioid Overdose

A wearable patch under development would detect opioid-related respiratory depression and administer rescue ...

JULY 18, 2022

Perioperative Gabapentinoids Provide No Benefit in Arthroplasty

Montreal—Same day administration of gabapentinoids for arthroplasty could have several negative outcomes ...

OCTOBER 17, 2019

‘You Have to Put Some Value on Human Life’: Naloxone White Paper Under Fire

The incendiary response from the medical community to the working white paper written by two economists on the ...

JULY 9, 2018

Surgeon General’s Advisory Emphasizes Importance of Naloxone Amid Opioid Crisis

Surgeon General Jerome M. Adams, MD, MPH, in a public health advisory, recommended that more people, such as family ...

APRIL 6, 2018

Pharmacists Key To Expanding Naloxone Distribution

Community and hospital pharmacists are being trained to help make naloxone easier to obtain and use for people who ...

JUNE 28, 2016

Load more